Methods for using the mouse lymphoma assay to screen for chemical mutagenicity and photo-mutagenicity

Methods in Pharmacology and Toxicology

Volumn , Issue , 2014, Pages 561-592

  Mei, Nan ^a   Guo, Xiaoqing ^a   Moore, Martha M ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Chromosomal mutation; Gene mutation; Mouse lymphoma assay; Mutagenicity

Indexed keywords

AGAR;

ANIMAL CELL; ARTICLE; ASSAY; CHEMICAL ANALYSIS; CHEMICAL MUTAGENICITY; CHROMOSOME ANALYSIS; CONTROLLED STUDY; COULTER COUNTER; DATA ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; INFORMATION PROCESSING; LABORATORY DEVICE; LABORATORY TEST; MOUSE; MOUSE LYMPHOMA ASSAY; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PHOTOMUTAGENICITY; PRIORITY JOURNAL;

EID: 84891904722     PISSN: 15572153     EISSN: 19406053     Source Type: Book Series    
DOI: 10.1007/978-1-62703-742-6_34     Document Type: Article

References (36)

1. Clive D, Flamm WG, Machesko MR, Bernheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16:77-87
2. Cole J, Arlett CF, Green MH, Lowe J, Muriel W (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat Res 111: 371-386
3. Applegate ML, Moore MM, Broder CB et al (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci USA 87:51-55
4. Clements J (2000) The mouse lymphoma assay. Mutat Res 455:97-110
5. Liechty MC, Scalzi JM, Sims KR et al (1998) Analysis of large and small colony L5178Y tk -/-mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: Detection of recombination. Mutagenesis 13:461-474
6. Honma M, Momose M, Sakamoto H, Sofuni T, Hayashi M (2001) Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat Res 493: 101-114
7. Wang J, Sawyer JR, Chen L et al (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol Sci 109: 96-105
8. FDA (2000) Redbook 2000: IV.C.1.c mouse lymphoma thymidine kinase gene mutation assay. h t t p : //wwwfdagov/Food/Guidance ComplianceRegulatoryInformation/Guidance Documents/FoodIngredientsandPackaging/ Redbook/ucm078336htm
9. Dearfi eld KL, Auletta AE, Cimino MC, Moore MM (1991) Considerations in the US Environmental Protection Agency's testing approach for mutagenicity. Mutat Res 258: 259-283
10. ICH (1995) Topic S2A genotoxicity: Guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. In: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, harmonised tripartite guideline CPMP/ICH/141/95. Approved Sept 1995. http://www.ifpma.org/ich1.html
11. Muller L, Kikuchi Y, Probst G et al (1999) ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact. Mutat Res 436:195-225
12. ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). Approved Nov 2011. http://www.ich.org/fi leadmin/Public-Web-Site/ICH-Products/Guidelines/Safety/S2- R1/Step4/S2R1-Step4.pdf
13. OECD (1997) In vitro mammalian cell gene mutation test, OECD guideline for testing of chemicals, no. 476. http://wwwoecdorg/chemicalsafety/ assessmentofchemicals/19484 26pdf
14. Moore MM, Honma M, Clements J et al (2000) Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup Report. Environ Mol Mutagen 35:185-190
15. Moore MM, Honma M, Clements J et al (2002) Mouse lymphoma thymidine kinase gene mutation assay: Follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environ Mol Mutagen 40:292-299
16. Moore MM, Honma M, Clements J et al (2003) Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report-Plymouth, UK 2002. Mutat Res 540:127-140
17. Moore MM, Honma M, Clements J et al (2006) Mouse lymphoma thymidine kinase gene mutation assay: Follow-up meeting of the International Workshop on Genotoxicity Testing-Aberdeen, Scotland, 2003-Assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47:1-5
18. Moore MM, Honma M, Clements J et al (2007) Mouse lymphoma thymidine kinase gene mutation assay: Meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutat Res 627:36-40
19. Moore MM, Honma M, Clements J et al (2011) Suitable top concentration for tests with mammalian cells: Mouse lymphoma assay workgroup. Mutat Res 723:84-86
20. Hozier J, Sawyer J, Clive D, Moore M (1982) Cytogenetic distinction between the TK + and TK-chromosomes in the L5178Y TK +/- 3.7.2C mouse-lymphoma cell line. Mutat Res 105:451-456
21. Sawyer J, Moore MM, Clive D, Hozier J (1985) Cytogenetic characterization of the L5178Y TK +/- 3.7.2C mouse lymphoma cell line. Mutat Res 147:243-253
22. Moore-Brown MM, Clive D, Howard BE, Batson AG, Johnson KO (1981) The utilization of trifl uorothymidine (TFT) to select for thymidine kinase-deficient (TK -/-) mutants from L5178Y/TK +/- mouse lymphoma cells. Mutat Res 85:363-378
23. Clive D, Johnson KO, Spector JF, Batson AG, Brown MM (1979) Validation and characterization of the L5178Y/TK +/- mouse lymphoma mutagen assay system. Mutat Res 59:61-108
24. Moore MM, Clive D, Hozier JC et al (1985) Analysis of trifl uorothymidine-resistant (TFTr) mutants of L5178Y/TK +/- mouse lymphoma cells. Mutat Res 151:161-174
25. Moore MM, Clive D, Howard BE, Batson AG, Turner NT (1985) In situ analysis of trifl uorothymidine- resistant (TFTr) mutants of L5178Y/TK +/- mouse lymphoma cells. Mutat Res 151:147-159
26. Clark LS, Harrington-Brock K, Wang J et al (2004) Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells. Mutagenesis 19:263-268
27. Brendler-Schwaab S, Czich A, Epe B et al (2004) Photochemical genotoxicity: Principles and test methods. Report of a GUM task force. Mutat Res 566:65-91
28. Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T (2005) Photomutagenicity of retinyl palmitate by ultraviolet a irradiation in mouse lymphoma cells. Toxicol Sci 88:142-149
29. Mei N, Xia Q, Chen L, Moore MM, Chen T, Fu PP (2006) Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells. Chem Res Toxicol 19:1435-1440
30. Mei N, Hu J, Xia Q, Fu PP, Moore MM, Chen T (2010) Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells. Toxicol In Vitro 24:439-444
31. Gocke E, Muller L, Guzzie PJ et al (2000) Considerations on photochemical genotoxicity: Report of the International Workshop on Genotoxicity Test Procedures Working Group. Environ Mol Mutagen 35:173-184
32. Mei N, Chen T, Godar DE, Moore MM. UVAinduced photomutagenicity of retinyl palmitate. Mutat Res 2009;677:105-106; author reply 107-108
33. Lorge E (2013) Recommendations for good cell culture practices in genotoxicity testing. Genetic Toxicology Technical Committee, ILSI-HESI, Washington, DC (Personal Communication
34. Machanoff R, O'Neill JP, Hsie AW (1981) Quantitative analysis of cytotoxicity and mutagenicity of benzo[a]pyrene in mammalian cells (CHO/HGPRT system). Chem Biol Interact 34:1-10
35. Majeska JB, Matheson DW (1990) Development of an optimal S9 activation mixture for the L5178Y TK +/- mouse lymphoma mutation assay. Environ Mol Mutagen 16: 311-319
36. Honma M, Zhang LZ, Sakamoto H et al (1999) The need for long-Term treatment in the mouse lymphoma assay. Mutagenesis 14: 23-29